Allie O'Hara is a litigation and trial associate in the Orange County office of Latham & Watkins.

Ms. O’Hara advises public and private companies and their officers and directors in all aspects of litigation, including major motion practice, fact and expert discovery, trial, and appeals, primarily in connection with:

  • Securities class actions
  • State fraud claims
  • Contract disputes
  • Merger disputes
  • Shareholder derivative litigation
  • Other complex, high-exposure litigation

Ms. O’Hara has served on the firm’s Recruiting and Pro Bono Committees and was the Global Chair of the Hispanic and Latin American Lawyers Group. Ms. O’Hara maintains an active pro bono practice focused on impact litigation and appellate advocacy for survivors of domestic violence.

While in law school, Ms. O'Hara was a member of the Latin American Law Students Association, the International Women’s Human Rights Clinic, and a senior symposium editor for the Georgetown Journal of Gender and the Law.

Ms. O’Hara currently represents or has represented global companies spanning numerous industries, including technology, biotechnology, medical devices, semiconductors, telecommunications, insurance, financial institutions, and REITs.

Ms. O’Hara’s experience includes the following:

  • Currently representing Chairman and former CEO of insurtech company in founder’s dispute involving breach of contract, fraud, and insider trading claims
  • Currently representing electric vehicle, medical device, media, and technology companies in securities class actions and stockholder litigation in connection with financing and strategic transactions
  • Securing a complete defense jury verdict for NextGen Healthcare, Inc. in the first holder’s claim case to go to trial in the US in nearly 90 years. Hussein v. Razin et al. (Orange Cty. Sup. Ct. July 29, 2021)
  • Defeating more than 95% of plaintiffs’ claimed damages in rare Section 10(b) securities class action to go to jury verdict, named by the Daily Journal as one of the Top Verdicts of 2019. Hsu v. Puma Biotechnology, Inc. (C.D. Cal. February 4, 2019)
  • Achieving dismissal of former Banc of California Chairman and CEO in securities class action, with rare public statement by plaintiffs affirming CEO’s non-culpable conduct. In re Banc of California Sec. Litig. (C.D. Cal. 2019)
  • Achieving dismissal of vast majority of securities class action claims against Obalon Therapeutics and its officers and directors, leading to an early and highly favorable settlement
  • Arguing before California Court of Appeal and securing order remanding case to trial court with instructions to issue her client a restraining order
  • Reaching settlement to secure funding for Orange County’s homeless population

Bar Qualification

  • California


  • JD, Georgetown University Law Center, 2017
  • BA, University of California, Irvine, 2013
    cum laude, Phi Beta Kappa

Languages Spoken

  • English